Effects of Sufentanil on the Intraoperative Hemodynamics
Sponsored by Seoul National University Hospital
About this trial
Last updated 2 years ago
Study ID
Bypass-SFTN
Status
Recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
19+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started 2 years ago
What is this trial about?
This study is a randomized, controlled trial. A total of 92 patients will be randomized
to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.
What are the participation requirements?
Inclusion Criteria
- Patients who undergo elective extracranial-intracranial bypass surgery
- American Society of Anesthesiologists grade 1,2,3
- Age > 18 years old
Exclusion Criteria
- Refuse to participate to the study
- American Society of Anesthesiologists grade 4
- Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
- Allergic history of opioid
- pregnant
- MAO Inhibitor user
- Severe respiratory insufficiency
Locations
Location
Status
Recruiting